ohm: I don't believe that the wording of the statutes controlling the FDA can or will be found to be ambiguous in any way that will adversely affect any FDA approval for Leronlimab or FDA ruling favorable to CYDY. I am, however, more than a little concerned about future FDA rulings and decisions affecting CYDY and LL.